SCHEMBL16466367

SCHEMBL16466367

CCOC(=O)CCCN1CCC(C(=O)c2ccc(F)cc2)CC1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 3/20 0.59
HTR2C P28335 2/20 0.59
HTR7 P34969 2/20 0.59
HTR6 P50406 2/20 0.59
KDM4E B2RXH2 1/20 0.58
CYP1A2 P05177 1/20 0.58
CYP3A4 P08684 1/20 0.58
CYP2D6 P10635 1/20 0.58
MEN1 O00255 1/20 0.55
CHRM2 P08172 1/20 0.55
HTR1A P08908 1/20 0.55
ADRA2A P08913 1/20 0.55
DRD1 P21728 1/20 0.55
ADRA1A P35348 1/20 0.55
OPRM1 P35372 1/20 0.55
DRD3 P35462 1/20 0.55
KMT2A Q03164 1/20 0.55
KCNH2 Q12809 1/20 0.55
HRH3 Q9Y5N1 1/20 0.55
HRH2 P25021 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10925919 0.86 HTR2A (0.59) HTR2AHTR2CHTR7HTR6KDM4E
SCHEMBL14638486 0.85 SMN1; SMN2 (0.62) HTR2AHTR2CHTR7HTR6CYP2D6
SCHEMBL11939045 0.84 HTR2A (0.69) HTR2AHTR2CHTR7HTR6KDM4E
Hydrochloric Acid SCHEMBL11297338 0.83 HTR2A (0.64) HTR2AHTR2CHTR7HTR6KDM4E
Bromide SCHEMBL11296700 0.83 HTR2A (0.64) HTR2AHTR2CHTR7HTR6KDM4E
Hydrochloric Acid SCHEMBL9232045 0.83 HTR2A (0.58) HTR2AHTR2CHTR7HTR6KDM4E
Lenperone SCHEMBL121686 0.83 MEN1 (0.74) HTR2AHTR2CHTR7HTR6KDM4E
SCHEMBL4981971 0.83 HTR2A (0.67) HTR2AHTR2CHTR7HTR6KDM4E
Lenperone SCHEMBL11453463 0.82 MEN1 (0.72) HTR2AHTR2CHTR7HTR6KDM4E
SCHEMBL10963542 0.81 HTR2A (0.54) HTR2AHTR2CHTR7HTR6KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10118892-B2 Compounds and their synthesis UCL BUSINESS PLC (GB) 2018-11-06 US disclosed
US-20150266818-A1 COMPOUNDS AND THEIR SYNTHESIS UCL BUSINESS PLC (GB) 2015-09-24 US disclosed
EP-2906548-A1 COMPOUNDS AND THEIR SYNTHESIS UCL Business Plc. (GB) 2015-08-19 EP disclosed
WO-2014057291-A1 COMPOUNDS AND THEIR SYNTHESIS UCL BUSINESS PLC (GB) 2014-04-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150266818-A1 COMPOUNDS AND THEIR SYNTHESIS ARSA, CCNL2, ATXN2L HTR2A 4107/4885HTR2C 3162/4885HTR7 3139/4885
US-10118892-B2 Compounds and their synthesis ARSA, ATXN2L, CCNL2 HTR2A 4065/4885HTR2C 3085/4885HTR7 2959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.